摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

decarestrictine O | 152053-15-1

中文名称
——
中文别名
——
英文名称
decarestrictine O
英文别名
(2R,4S,5S,6E,8S)-4,5,8-trihydroxy-2-methyl-2,3,4,5,8,9-hexahydrooxecin-10-one
decarestrictine O化学式
CAS
152053-15-1
化学式
C10H16O5
mdl
——
分子量
216.234
InChiKey
KYLGPSQYGNCTQJ-XYEXOTNWSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    -0.8
  • 重原子数:
    15
  • 可旋转键数:
    0
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.7
  • 拓扑面积:
    87
  • 氢给体数:
    3
  • 氢受体数:
    5

SDS

SDS:774a95fab85e74fad9b3aa5cf36ec9ea
查看

反应信息

点击查看最新优质反应信息

文献信息

  • Synthesis of Ophiocerins A, B and C, Botryolide E, Decarestrictine O, Stagonolide C and 9-<i>epi</i>-Stagonolide C Employing Chiral Hexane-1,2,3,5-tetraol Derivatives as Building Blocks
    作者:Krishanu Show、Pradeep Kumar
    DOI:10.1002/ejoc.201600625
    日期:2016.9
    organocatalytic approach to the synthesis of (2R,3S)-hexane-1,2,3,5-tetraol (11) derivatives (in the forms of different stereoisomers and bearing different protecting groups) has been developed. The key chiral intermediates 11 were prepared with complete stereocontrol through the proline-catalyzed intermolecular aldol reaction between acetone and d-glyceraldehyde acetonide. The synthetic utility of the
    已开发出一种合成 (2R,3S)-己烷-1,2,3,5-四醇 (11) 衍生物(以不同立体异构体形式并带有不同保护基团)的有机催化方法。关键的手性中间体11是通过丙酮和d-甘油醛缩​​醛之间的脯氨酸催化的分子间醛醇反应在完全立体控制下制备的。通过标准合成方案将中间体转化为标题羟基化吡喃和各种不饱和内酯,证明了中间体的合成效用。
  • Stereoselective total synthesis of decarestrictine O
    作者:Jhillu S. Yadav、K. Anantha Lakshmi、N. Mallikarjuna Reddy、Nipunge Swapnil、A. Ramachandra Prasad
    DOI:10.1016/j.tetasy.2012.06.027
    日期:2012.8
    The stereoselective total synthesis of decarestrictine O, a polyketide natural product is described. The synthesis involves MacMillan α-hydroxylation, C1-Wittig olefination, hydrolytic kinetic resolution and ring closing metathesis (RCM) as key steps. Improved efficiency was achieved by using the DIBAL mediated reductive transformation of trans-dimethyl l-tartrate acetonide into ε-hydroxy α,β-unsaturated
    描述了去甲乙胺啶醇(一种聚酮化合物天然产物)的立体选择性全合成。合成过程涉及MacMillanα-羟基化,C 1 -Wittig烯化,水解动力学拆分和闭环复分解(RCM)等关键步骤。通过使用DIBAL介导的一步法将酒石酸二甲酯反式转化为ε-羟基α,β-不饱和酯,可以提高效率。
  • First stereoselective total synthesis of decarestrictine O via RCM protocol
    作者:Palakodety Radha Krishna、T. Jagannadha Rao
    DOI:10.1016/j.tetlet.2010.05.064
    日期:2010.8
    A convergent first stereoselective total synthesis of decarestrictine O via RCM protocol starting from 1,3-propanediol and propylene oxide is reported.
    据报道,从1,3-丙二醇和环氧丙烷开始,通过RCM协议,对脱卡因汀O进行了聚合的第一立体选择性全合成。
  • A facile chiral pool synthesis of 9-epi-decarestrictine-D, decarestrictine-D and O
    作者:Kuchena Vamshikrishna、Garlapati Srinu、Pabbaraja Srihari
    DOI:10.1016/j.tetasy.2013.12.008
    日期:2014.2
    A facile chiral pool total synthesis of 9-epi-decarestrictine-D, decarestrictine-D and O has been achieved from L-(+)-diethyl tartrate. The strategy utilized is conventional and flexible. Wittig homologation and Grubbs ring closing metathesis are the key reactions employed for the synthesis of the title molecules. (C) 2013 Elsevier Ltd. All rights reserved.
查看更多

同类化合物

胰岛素原(cattle),29-[N6-[[2-(甲磺酰)乙氧基]羰基]-L-赖氨酸]-59-[N6-[[2-(甲磺酰)乙氧基]羰基]-L-赖氨酸]-(9CI) 十氢-2,7-苯并二氧杂环癸烷-3,6-二酮 二环<3.3.0>-2-氧杂-5-(2-丙烯基)-1-辛烯 乙烯邻苯二甲酸酯 [(E,1R)-1-[(2R,4Z,7S,8R)-7-溴-8-乙基-3,6,7,8-四氢-2H-氧杂环辛三烯-2-基]己-3-烯-5-炔基]乙酸酯 [(2R,3S,4E,6R,7S)-6,7-二羟基-2-甲基-10-氧代-2,3,6,7,8,9-六氢氧杂环辛三烯-3-基] (E)-丁-2-烯酸酯 6,7-二氢-5aH-氧杂环丁烷并[3,2-d][1,3]苯并二氧戊环 5-氧杂-10-氮杂三环[5.3.1.03,8]十一碳-1(10),2,6,8-四烯 3-氧杂二环[3.3.1]壬-6-烯-9-酮 3,4,5,6-四氢-2,7-苯并二氧杂环癸烷e-1,8-二酮 10-(乙酰氧基)-4,5,6,7-四氢-2H-1-苯并氧杂环辛三烯-2,8(3H)-二酮 1-(2,3,4,5-四氢-1,6-苯并二噁辛英-8-基)丙烷-1-酮 1,2-环己烷二甲酸1-甲基-1,2-乙二基酯 (S)-5-烯丙基-2-氧杂双环[3.3.0]辛-8-烯 (7Z)-2-(3-溴丙-1,2-二烯基)-5-(1-溴丙基)-3,3a,5,6,9,9a-六氢-2H-呋喃并[3,2-b]氧杂环辛三烯 (7E)-4,7-二羟基-10-甲基-3,4,5,6,9,10-六氢氧杂环辛三烯-2-酮 (6Z)-10-甲基-3,4,5,8,9,10-六氢-2H-氧杂环辛三烯-2-酮 (5Z,8S)-3-氯-2-[(E)-戊-2-烯-4-炔基]-8-[(E)-丙-1-烯基]-3,4,7,8-四氢-2H-氧杂环辛三烯 (4Z)-3,6-二氢-2,7-苯并二氧杂环癸烷e-1,8-二酮 (4S,5Z,7S,8S,10R)-4,7,8-三羟基-10-甲基-3,4,7,8,9,10-六氢氧杂环辛三烯-2-酮 (4R,5R,6Z,8S,10R)-4,5,8-三羟基-10-甲基-3,4,5,8,9,10-六氢氧杂环辛三烯-2-酮 (2R,5Z)-8a-[(R)-1-溴丙基]-3a-氯-3,4,7,8-四氢-2a-[(Z)-2-戊烯-4-炔基]-2H-氧杂环辛三烯 1,3,3a,6a-tetrahydro-5-pentyl-4H-cyclopentafuran-4-one trans-1-oxacyclodec-7-ene-2-one 2-epi-herbarumin II (RS)-5-methoxy-2,3,5,6-tetrahydro-8H-benzo[1,4,7]trioxecin β-heptenolactone stagonolide-E fumaric acid butanediyl ester aspinolide A (3R,4R,9S,10R,Z)-4,9-dihydroxy-3-methyl-10-pentyl-3,4,7,8,9,10-hexahydro-2H-oxecin-2-one prelaureatin 8-acetyl-4,4-dimethyl-2,6-dioxo-9-(2-methylpropyl)-2,3,4,5,6,8-hexahydrooxocino[2,3-c]pyrrole 5,6-benzo-2,3-diethoxy-4-oxo-2-hepten-7-olide 3,4,5,6-tetrahydro-oxocin-2-one (Z)-3-butyl-5,6,7,8-tetrahydro-2H-oxocin-2-one presaccharothriolide X 1-{2-[4,5-dihydro-1H-2-benzoxocin-(6Z)-ylidenemethyl]-allyl}-piperidine (R,Z)-8-(methoxymethoxy)-2,2,6,9-tetramethyl-5,6-dihydro-2H-benzo[b]oxocine 5-hydroxy-7R,11-heliannan-10-one 8-methoxy-2,2,6,9-tetramethyl-2H-1-benzoxocin-3(4H)-one 8-methoxy-2,2,6,9-tetramethyl-3,4,5,6-tetrahydro-2H-1-benzoxocin-3-ol (4S,5Z,10R)-4-hydroxy-10-methyl-3,4,7,8,9,10-hexahydro-2H-oxecin-2-one (4R)-9,11-bis(benzyloxy)-4-methyl-4,5,6,7-tetrahydro-1H-benzo[d]-oxecine-2,8-dione ethyl (4Z)-4-methyl-7,8-dihydro-1,3,6-trioxocine-5-carboxylate 4-hydroxy-10-(2-hydroxyethyl)-1,2-dihydro-4,12a-methanooxocino[4,5-b][1,4]benzodioxin-5-one 4-hydroxy-9-(2-hydroxyethyl)-1,2-dihydro-4,12a-methanooxocino[4,5-b][1,4]benzodioxin-5-one (7R,9R,5E)-7-hydroxy-9-propylnon-5-en-9-olide (6S,7R,9R)-6,7-dihydroxy-9-propylnon-4-eno-9-lactone 7-[2-(3,5-Dichloro-N-oxo-pyridin-4-yl)-1-oxoethyl]-10-methoxy-2,3,4,5-tetrahydro-1,6-benzodioxocine